Literature DB >> 28987073

Human Microbiome as an Approach to Personalized Medicine.

Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Bagher Larijani.   

Abstract

Personalized medicine is an approach for medical decisions, practices, and interventions that considers individual variations in genes, environment, and lifestyle for each person. Regarding complex metabolic patterns associated with different diseases, characterizing unique metabolic patterns of each patient seems like a practical approach. We can imagine a future in which routinely analyzing the microbiome allows us to predict individualized responses to different foods and drugs. Microbiome analysis of individuals may be added to future routine personalized medicine protocols after comparing the costs and benefits of microbiome-sequencing technology. Moreover, improved understanding of the human microbiome could lead to the development of novel therapeutic strategies for different diseases. Potential therapeutic agents, such as personalized probiotic and prebiotic supplements, dietary interventions, and fecal microbiota transplantation that can be used to reshape the gut microbiome, represent a reasonable strategy in an era of personalized medicine.

Entities:  

Mesh:

Year:  2017        PMID: 28987073

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  8 in total

Review 1.  Gut microbiota: a perspective of precision medicine in endocrine disorders.

Authors:  Salman Shirvani Rad; Amirabbas Nikkhah; Mohammadmahdi Orvatinia; Hanieh-Sadat Ejtahed; Negar Sarhangi; Seyed Hamid Jamaldini; Nazli Khodayari; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2020-08-12

Review 2.  The promise of the gut microbiome as part of individualized treatment strategies.

Authors:  Daniel A Schupack; Ruben A T Mars; Dayne H Voelker; Jithma P Abeykoon; Purna C Kashyap
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

3.  Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults.

Authors:  Hanieh-Sadat Ejtahed; Zahra Hoseini-Tavassol; Shohre Khatami; Mehrangiz Zangeneh; Ava Behrouzi; Sara Ahmadi Badi; Arfa Moshiri; Shirin Hasani-Ranjbar; Ahmad-Reza Soroush; Farzam Vaziri; Abolfazl Fateh; Mostafa Ghanei; Saeid Bouzari; Shahin Najar-Peerayeh; Seyed Davar Siadat; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2020-02-08

4.  The impact of genome variation and diet on the metabolic phenotype and microbiome composition of Drosophila melanogaster.

Authors:  Lisa Jehrke; Fiona A Stewart; Andrea Droste; Mathias Beller
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

Review 5.  Worldwide trends in scientific publications on association of gut microbiota with obesity.

Authors:  Hanieh-Sadat Ejtahed; Ozra Tabatabaei-Malazy; Ahmad-Reza Soroush; Shirin Hasani-Ranjbar; Seyed-Davar Siadat; Jeroen Raes; Bagher Larijani
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

6.  Changes in Plasma Choline and the Betaine-to-Choline Ratio in Response to 6-Month Lifestyle Intervention Are Associated with the Changes of Lipid Profiles and Intestinal Microbiota: The ICAAN Study.

Authors:  HanByul Jang; Hyunjung Lim; Kyung-Hee Park; SangIck Park; Hye-Ja Lee
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

Review 7.  Gut microbiota modulation as a possible mediating mechanism for fasting-induced alleviation of metabolic complications: a systematic review.

Authors:  Pooneh Angoorani; Hanieh-Sadat Ejtahed; Shirin Hasani-Ranjbar; Seyed Davar Siadat; Ahmad Reza Soroush; Bagher Larijani
Journal:  Nutr Metab (Lond)       Date:  2021-12-14       Impact factor: 4.169

8.  Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment.

Authors:  Zahra Hoseini-Tavassol; Shirin Hasani-Ranjbar
Journal:  J Diabetes Metab Disord       Date:  2021-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.